Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 3.87 USD 7.5% Market Closed
Market Cap: 219.7m USD

Wall Street
Price Targets

DSGN Price Targets Summary
Design Therapeutics Inc

Wall Street analysts forecast DSGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DSGN is 7.48 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Lowest
Price Target
5.05 USD
30% Upside
Average
Price Target
7.48 USD
93% Upside
Highest
Price Target
12.6 USD
226% Upside
Design Therapeutics Inc Competitors:
Price Targets
PTGX
Protagonist Therapeutics Inc
54% Upside
CUV
Clinuvel Pharmaceuticals Ltd
151% Upside
6855
Ascentage Pharma Group International
12% Upside
ACLX
Arcellx Inc
81% Upside
ALNY
Alnylam Pharmaceuticals Inc
14% Upside
ANAB
AnaptysBio Inc
84% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
36% Downside
KALV
Kalvista Pharmaceuticals Inc
142% Upside

Revenue
Forecast

Revenue Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Design Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DSGN's stock price target?
Price Target
7.48 USD

According to Wall Street analysts, the average 1-year price target for DSGN is 7.48 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Back to Top